Gefitinib EP Impurity A - CAS 199327-61-2
Catalog: |
BB015388 |
Product Name: |
Gefitinib EP Impurity A |
CAS: |
199327-61-2 |
Synonyms: |
Gefitinib Impurity 12; 7-Methoxy-6-(3-morpholin-4-ylpropoxy)-1H-quinazolin-4-one; 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one; 7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(3H)-quinazolinone; 7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one; 7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4-one; 7-Methoxy-6-[3-(4-morpholinyl)propoxy]quinazolin-4(3H)-one |
IUPAC Name: | 7-methoxy-6-(3-morpholin-4-ylpropoxy)-3H-quinazolin-4-one |
Description: | An impurity of Gefitinib. Gefitinib is a first-generation EGFR tyrosine kinase inhibitor used primarily to treat non-small cell lung cancer (NSCLC) in patients with specific EGFR mutations. |
Molecular Weight: | 319.36 |
Molecular Formula: | C16H21N3O4 |
Canonical SMILES: | COC1=C(C=C2C(=C1)N=CNC2=O)OCCCN3CCOCC3 |
InChI: | InChI=1S/C16H21N3O4/c1-21-14-10-13-12(16(20)18-11-17-13)9-15(14)23-6-2-3-19-4-7-22-8-5-19/h9-11H,2-8H2,1H3,(H,17,18,20) |
InChI Key: | WFUBWLXSYCFZEH-UHFFFAOYSA-N |
Boiling Point: | 519.5±60.0 °C at 760 mmHg |
Melting Point: | 248-250 °C |
Purity: | ≥95% |
Density: | 1.32±0.1 g/cm3 |
Solubility: | Soluble in DMSO (Slightly), Methanol (Slightly) |
Appearance: | White to Off-white Solid |
Storage: | Store at 2-8 °C |
LogP: | 0.97070 |
GHS Hazard Statement: | H412: Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] |
Precautionary Statement: | P273, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-112300082-A | Phenyl piperazine quinazoline compound or pharmaceutically acceptable salt thereof, preparation method and application | 20190726 |
WO-2021017996-A1 | Phenylpiperazine quinazoline compound or pharmaceutically acceptable salt thereof, and preparation method therefor and use thereof | 20190726 |
CN-111298127-A | Composition comprising histamine release-promoting substance and inhibitory compound, and oral solid preparation containing the same | 20190619 |
CN-107098863-A | A kind of preparation method of Gefitinib | 20170526 |
CN-107098863-B | Preparation method of gefitinib | 20170526 |
Complexity: | 426 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 319.15320616 |
Formal Charge: | 0 |
Heavy Atom Count: | 23 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 319.15320616 |
Rotatable Bond Count: | 6 |
Topological Polar Surface Area: | 72.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Morpholines/Thiomorpholines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS